Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | CHD3 |
Upstream (Parents) |
---|
(<<) FMO4 → CHD3 |
(<<) LEPR → CHD3 |
(<<) CES2 → CHD3 |
(<<) MFSD10 → CHD3 |
(<<) SLC1A2 → CHD3 |
(<<) UBC///UBB///RPS27A → CHD3 |
Downstream (Children) |
---|
CHD3 → ADRA2B (>>) |
CHD3 → LARP4B (>>) |
CHD3 → ATP6V0A2 (>>) |
CHD3 → C3orf36 (>>) |
CHD3 → C16orf57 (>>) |
CHD3 → DVL2 (>>) |